Loading company…
Velicept Therapeutics, based in Pennsylvania, is a clinical-stage drug developer working on solabegron for bladder and bowel disorders.
Founded in 2015 and based in Wayne, Pennsylvania, US, Velicept Therapeutics is a clinical-stage pharmaceutical company developing solabegron. The drug is being developed to treat overactive bladder and irritable bowel syndrome. Its listed stage is Series B.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in